Since high KLF5 mRNA and protein levels have been reported as a potent biomarker for unfavourable prognosis for breast cancer patients, we tried to test whether BAP1 can also serve as a biomarker for prognosis for breast cancer patients. This evidence concerns the gene BAP1 and breast carcinoma.